References

  1. Helander, Herbert F. and Fändriks, Lars (2014) Surface area of the digestive tract -- revisited. Scand J Gastroenterol 49:681-9
  2. Wu, Xiangyue and Brewer, Gary (2012) The regulation of mRNA stability in mammalian cells: 2.0. Gene 500:10-21
  3. Lee, J. H. et al. (2001) Crystal structure of rabbit phosphoglucose isomerase complexed with its substrate D-fructose 6-phosphate. Biochemistry 40:7799-805
  4. Larion, Mioara and Miller, Brian G. (2012) Homotropic allosteric regulation in monomeric mammalian glucokinase. Arch Biochem Biophys 519:103-11
  5. Meglasson, M. D. and Matschinsky, F. M. (1983) Discrimination of glucose anomers by glucokinase from liver and transplantable insulinoma. J Biol Chem 258:6705-8
  6. Raggi, F. and Kronfeld, D. S. (1966) Higher glucose affinity of hexokinase in sheep brain than in rat brain. Nature 209:1353-1354
  7. Zhao, Feng-Qi and Keating, Aileen F. (2007) Functional properties and genomics of glucose transporters. Curr Genomics 8:113-28
  8. Bode, J. C. et al. (1973) Depletion of liver adenosine phosphates and metabolic effects of intravenous infusion of fructose or sorbitol in man and in the rat. Eur J Clin Invest 3:436-41
  9. Ning, C. et al. (2000) Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency. Pediatr Res 48:211-7
  10. Panis, Bianca et al. (2006) Untreated classical galactosemia patient with mild phenotype. Mol Genet Metab 89:277-9
  11. Leslie, Nancy D. (2003) Insights into the pathogenesis of galactosemia. Annu Rev Nutr 23:59-80
  12. Berry, Gerard T. (2011) Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?. J Inherit Metab Dis 34:345-55
  13. Holton, J. B. et al. (1981) Galactosaemia: a new severe variant due to uridine diphosphate galactose-4-epimerase deficiency. Arch Dis Child 56:885-7
  14. Morgunov, I. and Srere, P. A. (1998) Interaction between citrate synthase and malate dehydrogenase. Substrate channeling of oxaloacetate. J Biol Chem 273:29540-4
  15. Graham, James W. A. et al. (2007) Glycolytic enzymes associate dynamically with mitochondria in response to respiratory demand and support substrate channeling. Plant Cell 19:3723-38
  16. Karpusas, M. et al. (1990) Proposed mechanism for the condensation reaction of citrate synthase: 1.9-A structure of the ternary complex with oxaloacetate and carboxymethyl coenzyme A. Biochemistry 29:2213-9
  17. Yagi, Takao and Matsuno-Yagi, Akemi (2003) The proton-translocating NADH-quinone oxidoreductase in the respiratory chain: the secret unlocked. Biochemistry 42:2266-74
  18. Liu, X. et al. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147-57
  19. Colell, A. et al. (2009) Novel roles for GAPDH in cell death and carcinogenesis. Cell Death Differ 16:1573-81
  20. Rastogi, V. K. and Girvin, M. E. (1999) Structural changes linked to proton translocation by subunit c of the ATP synthase. Nature 402:263-8
  21. Passarella, S. et al. (1984) Oxaloacetate uptake into rat brain mitochondria and reconstruction of the malate/oxaloacetate shuttle. Biochem Biophys Res Commun 119:1039-46
  22. Atlante, Anna et al. (2006) Mitochondria from the left heart ventricles of both normotensive and spontaneously hypertensive rats oxidize externally added NADH mostly via a novel malate/oxaloacetate shuttle as reconstructed in vitro. Int J Mol Med 18:177-86
  23. Safer, B. (1975) The Metabolic Significance of the Malate-Aspartate Cycle in Heart. Circ Res 37:527-33
  24. Barron, J. T. et al. (1998) Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle. J Mol Cell Cardiol 30:1571-9
  25. Divakaruni, Ajit S. and Brand, Martin D. (2011) The regulation and physiology of mitochondrial proton leak. Physiology (Bethesda) 26:192-205
  26. Sazanov, L. A. and Jackson, J. B. (1994) Proton-translocating transhydrogenase and NAD- and NADP-linked isocitrate dehydrogenases operate in a substrate cycle which contributes to fine regulation of the tricarboxylic acid cycle activity in mitochondria. FEBS Lett 344:109-16
  27. Chou, Chi-Yuan et al. (2009) Crystal structure of biotin carboxylase in complex with substrates and implications for its catalytic mechanism. J Biol Chem 284:11690-7
  28. Halperin, M. L. et al. (1971) The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria. A possible explanation for hypoglycemia in methylmalonic aciduria. J Clin Invest 50:2276-82
  29. Burchell, A. (1996) Endoplasmic reticulum phosphate transport. Kidney Int 49:953-8
  30. Goldsmith, E. et al. (1982) Structure of maltoheptaose by difference Fourier methods and a model for glycogen. J Mol Biol 156:411-27
  31. Roach, Peter J. et al. (2012) Glycogen and its metabolism: some new developments and old themes. Biochem J 441:763-87
  32. Sheng, Fang et al. (2009) The crystal structures of the open and catalytically competent closed conformation of Escherichia coli glycogen synthase. J Biol Chem 284:17796-807
  33. Shieh, Jeng-Jer et al. (2003) A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem 278:47098-103
  34. Nolte, L. A. et al. (1994) Epinephrine-induced in vivo muscle glycogen depletion enhances insulin sensitivity of glucose transport. J Appl Physiol (1985) 76:2054-8
  35. Cori, C. F. and Cori, G. T. (1929) Glycogen formation in the liver from D- and L-lactic acid. J Biol Chem 81:389-403
  36. Greene, H. L. et al. (1978) ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I. J Clin Invest 62:321-8
  37. Burwinkel, B. et al. (1997) Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase β subunit (PHKB). Hum Mol Genet 6:1109-15
  38. Worby, Carolyn A. et al. (2006) Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J Biol Chem 281:30412-8
  39. Racker, E. and Schroeder, E. (1957) Formation and utilization of octulose-8-phosphate by transaldolase and transketolase. Arch Biochem Biophys 66:241-3
  40. Veech, R. L. et al. (1969) The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem J 115:609-19
  41. Suagee, Jessica K. et al. (2010) De novo fatty acid synthesis and NADPH generation in equine adipose and liver tissue. Comp Biochem Physiol B Biochem Mol Biol 155:322-6
  42. Lyon, M. F. (1961) Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190:372-3
  43. Beutler, E. et al. (1962) The normal human female as a mosaic of X-chromosome activity: studies using the gene for G-6-PD-deficiency as a marker. Proc Natl Acad Sci U S A 48:9-16
  44. Carriere, F. et al. (1993) Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 105:876-88
  45. Gargouri, Y. et al. (1989) Gastric lipases: biochemical and physiological studies. Biochim Biophys Acta 1006:255-71
  46. Roulet, M. et al. (1980) Gastric emptying and lingual lipase activity in cystic fibrosis. Pediatr Res 14:1360-2
  47. van Stekelenburg, G. J. and Koorevaar, G. (1972) Evidence for the existence of mammalian acetoacetate decarboxylase: with special reference to human blood serum. Clin Chim Acta 39:191-9
  48. Koorevaar, G. and van Stekelenburg, G. J. (1976) Mammalian acetoacetate decarboxylase activity. Its distribution in subfractions of human albumin and occurrence in various tissues of the rat. Clin Chim Acta 71:173-83
  49. Casazza, J. P. et al. (1984) The metabolism of acetone in rat. J Biol Chem 259:231-6
  50. Reichard, G. A. Jr et al. (1979) Plasma acetone metabolism in the fasting human. J Clin Invest 63:619-26
  51. Sulway, M. J. and Malins, J. M. (1970) Acetone in diabetic ketoacidosis. Lancet 2:736-40
  52. Vining, Eileen P. G. (2002) The ketogenic diet. Adv Exp Med Biol 497:225-31
  53. Gasior, Maciej et al. (2007) The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia 48:793-800
  54. Palmer, Michael (2013) Combination treatment of epilepsy with ketogenic diet and concurrent pharmacological inhibition of cytochrome P450 2E1. Med Hypotheses 80:481-5
  55. Stern, J. R. (1971) A role of acetoacetyl-CoA synthetase in acetoacetate utilization by rat liver cell fractions. Biochem Biophys Res Commun 44:1001-7
  56. Endemann, G. et al. (1982) Lipogenesis from ketone bodies in the isolated perfused rat liver. Evidence for the cytosolic activation of acetoacetate. J Biol Chem 257:3434-40
  57. Buckley, B. M. and Williamson, D. H. (1975) Acetoacetyl-CoA synthetase; a lipogenic enzyme in rat tissues. FEBS Lett 60:7-10
  58. Puig, Teresa et al. (2009) Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity. Clin Cancer Res 15:7608-7615
  59. Sakakura, Y. et al. (2001) Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. Biochem Biophys Res Commun 286:176-83
  60. Goldstein, Joseph L. et al. (2006) Protein sensors for membrane sterols. Cell 124:35-46
  61. Steinberg, Daniel (2002) Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8:1211-7
  62. Rajamäki, Kristiina et al. (2010) Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5:e11765
  63. Martinon, Fabio et al. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-41
  64. Wang, Zeneng et al. (2007) Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13:1176-84
  65. Bhakdi, Sucharit et al. (2004) Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb Haemost 91:639-45
  66. Adams, D. (2005) The Hitchhiker's Guide to the Galaxy (Pan Macmillan).
  67. Bamm, Vladimir V. et al. (2004) Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43:3899-906
  68. Delanghe, J. et al. (1999) Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 145:287-92
  69. Goldberg, Alyse S. and Hegele, Robert A. (2012) Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib. Drug Des Devel Ther 6:251-9
  70. Lütjohann, D. et al. (2008) Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study. Int J Clin Pract 62:1499-510
  71. Tsubakio-Yamamoto, Kazumi et al. (2010) Current therapy for patients with sitosterolemia--effect of ezetimibe on plant sterol metabolism. J Atheroscler Thromb 17:891-900
  72. Brosnan, J. T. (2000) Glutamate, at the interface between amino acid and carbohydrate metabolism. J Nutr 130:988S-90S
  73. Yamada, Taro et al. (2003) Crystal structure of serine dehydratase from rat liver. Biochemistry 42:12854-65
  74. Loo, Y. H. (1974) Serotonin deficiency in experimental hyperphenylalaninemia. J Neurochem 23:139-47
  75. Woolf, L. I. (1986) The heterozygote advantage in phenylketonuria. Am J Hum Genet 38:773-5
  76. Sanger, F. (1988) Sequences, sequences, and sequences. Annu Rev Biochem 57:1-28
  77. Wahren, John et al. (2012) The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes 61:761-72
  78. Vayssière, B. M. et al. (1997) Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol 11:1245-55
  79. King, Elizabeth M. et al. (2013) Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms. PLoS One 8:e53936
  80. Russell, Steven T. et al. (2009) Mechanism of induction of muscle protein loss by hyperglycaemia. Exp Cell Res 315:16-25
  81. Nylen, Kirk et al. (2009) The ketogenic diet: proposed mechanisms of action. Neurotherapeutics 6:402-5
  82. Postolache, V. et al. (1969) [Effect of acetone upon barbiturate anesthesia]. Arch Toxikol 25:333-7
  83. MacDonald, K. S. et al. (2000) Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 181:1581-9
  84. Schemmel, Kate E. et al. (2010) Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications 24:354-60
  85. Colca, Jerry R. et al. (2013) Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins. PLoS One 8:e61551
  86. Divakaruni, Ajit S. et al. (2013) Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc Natl Acad Sci U S A 110:5422-7
  87. Miller, Russell A. et al. (2013) Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494:256-60
  88. Owen, M. R. et al. (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348 Pt 3:607-14
  89. Hawley, Simon A. et al. (2002) The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420-5
  90. Foretz, Marc et al. (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 120:2355-69
  91. Schirch, Verne and Szebenyi, Doletha Me (2005) Serine hydroxymethyltransferase revisited. Curr Opin Chem Biol 9:482-7
  92. Weir, D. G. and Scott, J. M. (1995) The biochemical basis of the neuropathy in cobalamin deficiency. Baillieres Clin Haematol 8:479-97
  93. van der Westhuyzen, J. et al. (1983) Effect of a vitamin B-12-deficient diet on lipid and fatty acid composition of spinal cord myelin in the fruit bat. J Nutr 113:531-7
  94. Aufreiter, Susanne et al. (2009) Folate is absorbed across the colon of adults: evidence from cecal infusion of (13)C-labeled [6S]-5-formyltetrahydrofolic acid. Am J Clin Nutr 90:116-23
  95. Hamid, Abid et al. (2009) New perspectives on folate transport in relation to alcoholism-induced folate malabsorption--association with epigenome stability and cancer development. FEBS J 276:2175-91
  96. McMartin, K. E. and Collins, T. D. (1983) Relationship of alcohol metabolism to folate deficiency produced by ethanol in the rat. Pharmacol Biochem Behav 18 Suppl 1:257-62
  97. Fernando, O. V. and Grimsley, E. W. (1998) Prevalence of folate deficiency and macrocytosis in patients with and without alcohol-related illness. South Med J 91:721-5
  98. Chan, Adriano et al. (2010) Cobinamide is superior to other treatments in a mouse model of cyanide poisoning. Clin Toxicol (Phila) 48:709-17
  99. Fujii, K. et al. (1982) Accumulation of 5-methyltetrahydrofolate in cobalamin-deficient L1210 mouse leukemia cells. J Biol Chem 257:2144-6
  100. Li, Shu-Xing et al. (2007) Octameric structure of the human bifunctional enzyme PAICS in purine biosynthesis. J Mol Biol 366:1603-14
  101. Van den Berghe, G. et al. (1992) The purine nucleotide cycle and its molecular defects. Prog Neurobiol 39:547-61
  102. Zöllner, N. and Gröbner, W. (1977) Dietary feedback regulation of purine and pyrimidine biosynthesis in man. Ciba Found Symp -:165-78
  103. Löffler, W. et al. (1982) Influence of dietary purines on pool size, turnover, and excretion of uric acid during balance conditions. Isotope studies using 15N-uric acid. Res Exp Med (Berl) 181:113-23
  104. Enomoto, Atsushi et al. (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447-52
  105. Feig, Daniel I. et al. (2004) Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 66:281-7
  106. Ramazzina, Ileana et al. (2006) Completing the uric acid degradation pathway through phylogenetic comparison of whole genomes. Nat Chem Biol 2:144-8
  107. Nyhan, W. L. (2000) Dopamine function in Lesch-Nyhan disease. Environ Health Perspect 108 Suppl 3:409-11
  108. Breese, G. R. et al. (1990) A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat. Brain Res Bull 25:477-84
  109. Choi, Hyon K. et al. (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277-81
  110. Kishibe, Mari et al. (2010) Chronic tophaceous gout secondary to self-induced vomiting in anorexia nervosa. J Dermatol 37:578-80
  111. Mehlhaff, D. L. and Stein, D. S. (1996) Gout secondary to ritonavir and didanosine. AIDS 10:1744
  112. Heuckenkamp, P. U. and Zöllner, N. (1971) Fructose-induced hyperuricaemia. Lancet 1:808-9
  113. Choi, Hyon K. and Curhan, Gary (2008) Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 336:309-12
  114. Oberhaensli, R. D. et al. (1987) Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy. Lancet 2:931-4
  115. Richette, Pascal et al. (2007) Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study. J Rheumatol 34:2093-8
  116. Tamba, M. and Torreggiani, A. (1998) A pulse radiolysis study of carnosine in aqueous solution. Int J Radiat Biol 74:333-40
  117. Boldyrev, A. A. (2012) Carnosine: new concept for the function of an old molecule. Biochemistry (Mosc) 77:313-26
  118. Boldyrev, Alexander A. et al. (2013) Physiology and pathophysiology of carnosine. Physiol Rev 93:1803-45
  119. Galmarini, Carlos M. et al. (2002) In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. Br J Haematol 117:860-8
  120. Cline, S. D. and Osheroff, N. (1999) Cytosine arabinoside lesions are position-specific topoisomerase II poisons and stimulate DNA cleavage mediated by the human type II enzymes. J Biol Chem 274:29740-3
  121. Cummings, T. F. (2004) The treatment of cyanide poisoning. Occup Med (Lond) 54:82-5
  122. Jaffe, Eileen K. (2004) The porphobilinogen synthase catalyzed reaction mechanism. Bioorg Chem 32:316-25
  123. Herrick, Ariane L. and McColl, Kenneth E. L. (2005) Acute intermittent porphyria. Best Pract Res Clin Gastroenterol 19:235-49
  124. Müller, W. E. and Snyder, S. H. (1977) Delta-aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. Ann Neurol 2:340-2
  125. Onishi, S. et al. (1986) Metabolism of bilirubin and its photoisomers in newborn infants during phototherapy. J Biochem 100:789-95
  126. Christensen, T. et al. (1994) Cells, bilirubin and light: formation of bilirubin photoproducts and cellular damage at defined wavelengths. Acta Paediatr 83:7-12
  127. Job, H. et al. (1996) Improvements in long term phototherapy for patients with Crigler-Najjar syndrome type I. Phys Med Biol 41:2549-56
  128. Kappas, A. et al. (2001) A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 108:25-30
  129. Ekroos, Marika and Sjögren, Tove (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc Natl Acad Sci U S A 103:13682-7
  130. Rashid, J. R. et al. (1992) Acetylation status using hydralazine in African hypertensives at Kenyatta National Hospital. East Afr Med J 69:406-8
  131. Golka, Klaus et al. (2002) The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences. Toxicol Lett 128:229-41
  132. Knox, R. J. et al. (1991) Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species. Biochem Pharmacol 42:1691-7
  133. Favaudon, V. (1982) On the mechanism of reductive activation in the mode of action of some anticancer drugs. Biochimie 64:457-75
  134. Welch, Ellen M. et al. (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447:87-91
  135. Goldmann, Tobias et al. (2012) A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation. EMBO Mol Med 4:1186-99
  136. Kerem, Eitan et al. (2008) Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 372:719-27
  137. Brunetti-Pierri, Nicola (2008) Gene therapy for inborn errors of liver metabolism: progress towards clinical applications. Ital J Pediatr 34:2
  138. Elford, H. L. and Lin, A. L. (1985) Adenosine deaminase impairment and ribonucleotide reductase in human cells. Ann N Y Acad Sci 451:98-112
  139. Benveniste, P. and Cohen, A. (1995) p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency. Proc Natl Acad Sci U S A 92:8373-7
  140. Joachims, Michelle L. et al. (2008) Inhibition of deoxynucleoside kinases in human thymocytes prevents dATP accumulation and induction of apoptosis. Nucleosides Nucleotides Nucleic Acids 27:816-20
  141. Wen, Jiaming et al. (2010) Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism. J Sex Med 7:3011-22
  142. Burnett, Arthur L. and Bivalacqua, Trinity J. (2008) Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism?. J Sex Med 5:237-40
  143. Polmar, S. H. et al. (1976) Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med 295:1337-43
  144. Gaspar, H. Bobby (2010) Bone marrow transplantation and alternatives for adenosine deaminase deficiency. Immunol Allergy Clin North Am 30:221-36
  145. Jevsevar, Simona et al. (2010) PEGylation of therapeutic proteins. Biotechnol J 5:113-28
  146. Aiuti, Alessandro et al. (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360:447-58
  147. van Capelle, C. I. et al. (2010) Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. Neuromuscul Disord 20:775-82
  148. Ghosh, Pradipta et al. (2003) Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol 4:202-12
  149. McVie-Wylie, A. J. et al. (2008) Biochemical and pharmacological characterization of different recombinant acid α-glucosidase preparations evaluated for the treatment of Pompe disease. Mol Genet Metab 94:448-55
  150. Barranger, J. A. and O'Rourke, E. (2001) Lessons learned from the development of enzyme therapy for Gaucher disease. J Inherit Metab Dis 24 Suppl 2:89-96
  151. Amory, J. K. et al. (2007) Miglustat has no apparent effect on spermatogenesis in normal men. Hum Reprod 22:702-7
  152. Mazzone, J. (2006) Copyfraud. New York University Law Review 81:1026-1098
  153. de Meis, Leopoldo et al. (2010) Fusion of the endoplasmic reticulum and mitochondrial outer membrane in rats brown adipose tissue: activation of thermogenesis by Ca2+. PLoS One 5:e9439